Skip to contentV
Vaxart, Inc.
V
VXRTVaxart, Inc. Q3 2021 · 10-Q
Revenue$200.00K$200.00K−24.5% vs Q3 2020 Net Income-$17.58M-$17.58MN/M vs Q3 2020 EPS Diluted-$0.14-$0.14N/M vs Q3 2020 Operating Income-$17,251,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$15,591,000N/M Margins · derivedOperating margin-8625.5%−5761.7 pt vs Q3 2020
Net margin-8791.5%−5740.6 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 4, 2021 · 35 d after period end